Brown Brothers Harriman & Co’s AtriCure ATRC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Hold	143	–	–	﹤0.01%	1616
2026 Q1	$4.08K	Sell	143 -23	-14%	-$785	﹤0.01%	1553
2025 Q4	$6.57K	Buy	+166	New	+$6.09K	﹤0.01%	1446
2025 Q2	–	Sell	-343	Closed	-$11.1K	–	1549
2025 Q1	$11.1K	Hold	343	–	–	﹤0.01%	1051
2024 Q4	$10.5K	Hold	343	–	–	﹤0.01%	1121
2024 Q3	$9.62K	Hold	343	–	–	﹤0.01%	1059
2024 Q2	$7.81K	Hold	343	–	–	﹤0.01%	994
2024 Q1	$10.4K	Hold	343	–	–	﹤0.01%	979
2023 Q4	$12.2K	Hold	343	–	–	﹤0.01%	922
2023 Q3	$15K	Hold	343	–	–	﹤0.01%	891
2023 Q2	$16.9K	Hold	343	–	–	﹤0.01%	890
2023 Q1	$14.2K	Hold	343	–	–	﹤0.01%	943
2022 Q4	$15.2K	Sell	343 -255	-43%	-$10.7K	﹤0.01%	944
2022 Q3	$23K	Buy	+598	New	+$27.4K	﹤0.01%	936

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Brown Brothers Harriman & Co's ATRC Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its AtriCure (ATRC) position steady in Q2 2026 at 143 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Brown Brothers Harriman & Co first reported a position in ATRC in Q3 2022 and has held it in 14 quarters since. The position peaked at $23K in Q3 2022. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Brown Brothers Harriman & Co held 143 shares of AtriCure worth $4K as of Q2 2026.
Brown Brothers Harriman & Co left its AtriCure share count unchanged in Q2 2026.
AtriCure made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1616 holding.
Brown Brothers Harriman & Co first reported a position in AtriCure in Q3 2022 and has held it in 14 quarters since.
Brown Brothers Harriman & Co's AtriCure position peaked at $23K in Q3 2022.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.